SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-18-004070
Filing Date
2018-10-12
Accepted
2018-10-12 17:00:04
Documents
8
Period of Report
2018-10-10
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 6880
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 10061
3 GRAPHIC exhibit99-1x3x1.jpg GRAPHIC 2966
4 GRAPHIC exhibit99-1x3x2.jpg GRAPHIC 2679
5 GRAPHIC exhibit99-1x4x1.jpg GRAPHIC 2562
6 GRAPHIC exhibit99-1x4x2.jpg GRAPHIC 2744
7 GRAPHIC exhibit99-1x5x1.jpg GRAPHIC 1108
8 GRAPHIC exhibit99-1x5x2.jpg GRAPHIC 1078
  Complete submission text file 0001062993-18-004070.txt   37232
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 181120725
SIC: 1000 Metal Mining